oleanolic acid has been researched along with aphidicolin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Basile, L; Copani, A; Giuffrida, ML; Guccione, S; Merlo, S; Sortino, MA | 1 |
| Fallarero, A; Hanski, L; Isojärvi, J; Karhu, E; Vuorela, P | 1 |
3 other study(ies) available for oleanolic acid and aphidicolin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity.
Topics: Alzheimer Disease; Cell Cycle; Cell Death; Cell Division; DNA Polymerase beta; DNA Replication; Enzyme Inhibitors; Flavones; Humans; Molecular Structure; Neurons; Neuroprotective Agents; Parkinson Disease | 2015 |
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
Topics: Anti-Bacterial Agents; Azithromycin; Biological Products; Cell Line; Cell Survival; Chlamydophila pneumoniae; Drug Discovery; Humans; Ligands; Microbial Sensitivity Tests; Molecular Structure | 2017 |